Vitamin E for the Prevention of Chemotherapy-Induced Peripheral Neuropathy: A meta-Analysis
Open Access
- 13 May 2021
- journal article
- review article
- Published by Frontiers Media SA in Frontiers in Pharmacology
- Vol. 12
Abstract
Background: Vitamin E has been increasingly used to prevent chemotherapy-induced peripheral neuropathy (CIPN) in recent years. However, it is still unclear whether vitamin E can effectively prevent CIPN.Methods: We searched all clinical studies in the Embase, Cochrane Library, Clinicaltrials.gov, and PubMed databases from inception to December 2020. We performed a meta-analysis of 9 randomized controlled trials (RCTs) with 486 patients that compared the vitamin E group with the control group. Outcomes of the study were incidence of all-grade CIPN, incidence of severe CIPN, and the total neuropathy scores (TNS). Random effect models were used to make the meta-analysis results more cautious.Results: Notably, vitamin E significantly reduced the incidence of all-grade CIPN (overall risk ratio (RR) = 0.55, 95% CI: 0.36, 0.85, I2 = 77.3%, p = 0.007), and TNS (overall standard mean difference (SMD) = −0.64, 95% CI: −1.03, −0.25, I2 = 42.7%, p = 0.001). However, the results of the subgroup analysis, which included only double-blind RCTs, suggested that vitamin E did not significantly reduce the incidence of all-grade CIPN (overall RR = 0.52, 95% CI: 0.07, 4.06, I2 = 77.5%, p = 0.531). Moreover, there was no significant difference in the incidence of severe CIPN between these two arms (p = 0.440).Conclusion: The results of our meta-analysis suggests that vitamin E has a beneficial effect on the incidence and symptoms of CIPN. However, routine prophylactic use of vitamin E is still not recommended. Moreover, more high-quality double-blind RCTs are needed to further validate the effects of vitamin E in prevention of CIPN.Keywords
This publication has 34 references indexed in Scilit:
- Assessment of antioxidant supplementation on the neuropathic pain score and quality of life in diabetic neuropathy patients – A randomized controlled studyPharmacological Reports, 2014
- Neuropathic pain in cancerBritish Journal of Anaesthesia, 2013
- Protective Effects of Vitamin E on Chemotherapy-Induced Peripheral Neuropathy: A Meta-Analysis of Randomized Controlled TrialsInternational Journal for Vitamin and Nutrition Research, 2013
- Intrapleural Fibrinolytic Therapy for Treatment of Adult Parapneumonic Effusions and EmpyemasChest, 2012
- Peripheral Neuropathy with Microtubule-Targeting Agents: Occurrence and Management ApproachClinical Breast Cancer, 2011
- The use of vitamin E for the prevention of chemotherapy-induced peripheral neuropathy: results of a randomized phase III clinical trialSupportive Care in Cancer, 2010
- Vitamin E neuroprotection for cisplatin neuropathyNeurology, 2010
- Preventing Paclitaxel-Induced Peripheral Neuropathy: A Phase II Trial of Vitamin E SupplementationJournal of Pain and Symptom Management, 2006
- A randomized controlled trial evaluating the efficacy and safety of vitamin E supplementation for protection against cisplatin-induced peripheral neuropathy: final resultsSupportive Care in Cancer, 2006
- Vitamin E for prophylaxis against chemotherapy-induced neuropathyNeurology, 2005